Search
for
Sort by
Research 16
- Fixed-Drug Eruption due to Dextromethorphan
- New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
- A 2018 Approach to Combating Methotrexate Toxicity Folic Acid and Beyond.
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- New lifestyle drugs and somatoform disorders in dermatology
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality
- Spotlight Commentary: Importance of dose redefining in the process of drug repurposing
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Repurposed Drugs: Current Trends in Drug Discovery
- Anti-Amnesia-like Effect of Pinus densiflora Extract by Improving Apoptosis and Neuroinflammation on Trimethyltin-Induced ICR Mice
- ZALCITABINE